Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines

Cellular Immunology
D FliegerI G Schmidt-Wolf


With a new flow cytometric cytotoxicity assay, we examined the mechanism of action of chimeric mouse human anti-CD20 monoclonal antibody IDEC-C2B8. IDEC-C2B8 alone induced direct cytotoxicity in four of eight examined CD20-expressing lymphoma cell lines (RAJI, DAUDI, JOK-1, and WT100) at a concentration above 100 ng/ml. Moreover, after 4 h incubation in human serum, only a moderate complement-dependent cellular cytotoxicity (CDCC) was observed, whereas cytotoxicity increased markedly after 3 days of culture, indicating that combined direct cytotoxicity and CDCC were responsible. IDEC-C2B8 induced an effective antibody-dependent cellular cytotoxicity (ADCC) in seven of eight tested lymphoma cell lines when peripheral blood mononuclear cells were used as effector cells. ADCC was moderately enhanced by cytokine interleukin-2, whereas interleukin-12, interferon-alpha, and GM-CSF had no influence. Interestingly, we could demonstrate a correlation between CD32 expression on lymphoma cell lines and IDEC-C2B8-induced direct cytotoxicity, indicating that crosslinking of CD20 with CD32 may be involved in the mechanism of cytotoxicity. We propose that direct cytotoxicity, CDCC, and ADCC result in the marked elimination of CD20-expressing ...Continue Reading


Dec 1, 1992·European Journal of Immunology·M A Valentine, K A Licciardi
Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E A ClarkJ A Ledbetter
Nov 1, 1995·European Journal of Immunology·M HolderJ Gordon
Apr 1, 1996·British Journal of Haematology·F J SmiersI P Touw
Mar 1, 1996·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·S FunakoshiW J Murphy
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·M A GhetieE S Vitetta
Feb 7, 1998·The Journal of Biological Chemistry·J P DeansJ A Savage
Sep 17, 1998·Japanese Journal of Cancer Research : Gann·H TajiY Morishima
Feb 5, 1999·European Journal of Immunology·C LéveilléW Mourad

❮ Previous
Next ❯


Mar 25, 2009·Apoptosis : an International Journal on Programmed Cell Death·Jonna EevaJukka Pelkonen
Oct 18, 2002·Immunology·Julie P DeansMaria J Polyak
Jan 30, 2004·Annual Review of Medicine·William RastetterChristine A White
Jan 12, 2008·Annual Review of Medicine·Arturo Molina
Nov 21, 2007·Hematology·Celeste Bello, Eduardo M Sotomayor
Jan 1, 2009·OncoTargets and Therapy·Dennis A EichenauerHolger Schulz
Feb 4, 2014·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Usha PandeyGrace Samuel
Jun 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mark X YangAlexey L Margolin
Jul 16, 2014·Experimental Hematology·Sabine WestphalOlaf Penack
May 6, 2011·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Alfred HaidenbergerPeter Lukas
Sep 8, 2010·International Journal of Hematology·Yasuyuki MiyakeShigeru Chiba
Sep 6, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·S A JacobsK S McCarty
Oct 1, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Martin KolevRossen Donev
Dec 13, 2006·Cancer Immunology, Immunotherapy : CII·John F DijosephNitin K Damle
Mar 18, 2006·Apoptosis : an International Journal on Programmed Cell Death·I DanielsA P Haynes
Aug 5, 2003·Current Oncology Reports·Neeta Pandit-TaskarChaitanya R Divgi
Mar 7, 2007·Expert Review of Anticancer Therapy·Bridgette Collins-Burow, Edgardo S Santos
May 15, 2008·Expert Opinion on Biological Therapy·Siao-Yi Wang, George Weiner
Apr 16, 2013·Molecular Immunology·Maria Raitses Gurevich, Zvi Fishelson
Jun 11, 2011·Best Practice & Research. Clinical Haematology·Andrew R Rezvani, David G Maloney
Dec 16, 2010·Biochemical and Biophysical Research Communications·Mi LiWeijing Zhang
Mar 31, 2010·Seminars in Hematology·George J Weiner
Oct 8, 2015·Critical Reviews in Oncology/hematology·Narges SeyfizadehSara Huerta-Yepez
Oct 7, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Laszlo MarkaszLaszlo Szekely
Nov 19, 2002·Clinical Lymphoma·Francesco BertoniEmanuele Zucca
May 27, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Zhihong Chen, Mark S Freedman
Mar 27, 2007·The Journal of Pediatrics·Lisa B GiulinoUNKNOWN Pediatric and Platelet Immunology Committees of the TMH Clinical Trial Network
Apr 17, 2007·Current Problems in Pediatric and Adolescent Health Care·James B BusselE Richard Stiehm
Aug 16, 2008·Scandinavian Journal of Immunology·A M Mattila, S Meri
Aug 15, 2006·Advanced Drug Delivery Reviews·Leonard G Presta
Mar 22, 2016·The Indian Journal of Medical Research·Mythili KameswaranMeera Venkatesh

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.